Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Gilead Sciences Inc (NASDAQ:GILD)

72.21
BATS BZX Real-Time Price
As of 11:13am ET
 -0.15 / -0.21%
Today’s Change
71.39
Today|||52-Week Range
104.79
-28.64%
Year-to-Date
3 Beaten-Up Healthcare Stocks: Are They Bargains?
8:36am / MotleyFool.com - Paid Partner Content
Visualizing Financial Trends With Interactive Charts, Other Topics
Nov 29 / GuruFocus News - Paid Partner Content
5 Companies for Enterprising Investors Near 52-Week Lows
Dec 05 / GuruFocus News - Paid Partner Content
J&J (JNJ) Reportedly Approaches Actelion for Acquisition
Nov 25 / Zacks.com - Paid Partner Content
10 Low P/E Picks for the Enterprising Investor
Dec 05 / GuruFocus News - Paid Partner Content
The Worst Growth Dividend Stocks of 2016
Nov 23 / MotleyFool.com - Paid Partner Content
1 Quote Reveals Why Gilead Sciences Hasn't Bought Anybody Yet
Dec 05 / MotleyFool.com - Paid Partner Content
Galapagos (GLPG) Filgotinib in Phase III for Crohn's Disease
Nov 23 / Zacks.com - Paid Partner Content
NHS to launch three-year anti-HIV PrEP trial
Dec 04 / FT.com - Paid Partner Content
3 Inexpensive Top Stocks You've Overlooked This Fall
Nov 23 / MotleyFool.com - Paid Partner Content
5 Dividend Stocks to Buy in December
Dec 03 / MotleyFool.com - Paid Partner Content
When Will Gilead Sciences' Unlucky Streak End?
Nov 23 / MotleyFool.com - Paid Partner Content
3 Reasons Why Incyte Corporation Stock Could Soar in 2017
Dec 03 / MotleyFool.com - Paid Partner Content
Biotech Stock Roundup: Acorda Stops Ampyra PSWD Development, CRL for Spectrum's Qapzo...
Nov 23 / Zacks.com - Paid Partner Content
Forget Pfizer: Here Are 3 Better Dividend Stocks
Dec 02 / MotleyFool.com - Paid Partner Content
What Happened in Biotech in 2016?
Nov 22 / MotleyFool.com - Paid Partner Content
'Yuge' Sector Rotation Will Continue
Dec 01 / TheStreet.com - Paid Partner Content
Are Biogen and Gilead Sciences in Denial?
Nov 22 / MotleyFool.com - Paid Partner Content
Gilead Sciences, Inc.'s $10 Billion Mistake
Dec 01 / MotleyFool.com - Paid Partner Content
Court rules NHS can provide anti-HIV drug
Nov 10 / FT.com - Paid Partner Content
'Mad Money' Lightning Round: Gilead Sciences, Celgene, Express Scripts
Dec 01 / TheStreet.com - Paid Partner Content
Clinton defeat provides antidote to US drugmakers
Nov 10 / FT.com - Paid Partner Content
5 Things Gilead Sciences' CEO Just Said That You Need to Know
Nov 30 / MotleyFool.com - Paid Partner Content
Drug and biotech stocks soar on Trump victory
Nov 09 / CNNMoney.com
17 Questions With Gaspare Civiero of the Value Investor
Nov 30 / GuruFocus News - Paid Partner Content
US stocks defy fears of panic with steady open after Trump win
Nov 09 / FT.com - Paid Partner Content
Gilead Is a Strong Contrarian 'Buy'
Nov 29 / GuruFocus News - Paid Partner Content